Apple stock suffers worst day in more than four years after ‘Houdini-like move’ with earnings
‘The uncertainty that speculation breeds is rarely positive,’ BTIG writes of decision to eliminate unit-sales disclosures
All Posts in "Markets"
Mortgage rates slide as echoes of 2006 haunt the housing market
‘Not everything is coming up perfectly roses,’ says one housing-watcher
The true cost of an iPhone over your lifetime: $300,000
That’s how much you would make if you invested the money you spent on your smartphone from the age of 18 to 78
Stocks rally to close higher as S&P 500 logs first 3-day win streak in 6 weeks
Hopes for a resolution to the U.S.-China trade spat may help to extend the rally
Asian markets surge; Chinese stocks jump as trade tensions ease
Apple suppliers not hurt by tech giant’s after-hours plunge
Dollar logging best month since May as euro tumbles 2.5% in October
Major currency pairs saw trading stabilize early Wednesday, as investors waded through economic data from the eurozone, China, and the U.S.
GE stock dips into single-digit territory as fear of the unknown trumps hope
One analyst says there is too much uncertainty to buy the stock, another says things are so bad they have to get better
Nikkei lags, but other Asian markets gain to open November
Telecom stocks dive in Japan; Chinese stocks surge
Stocks end an ugly October on an up note as S&P 500 suffers biggest monthly fall in 7 years
Nasdaq’s 9.2% monthly fall is biggest since November 2008
Dollar defends gains thanks to China trade deal optimism
Euro volatile after eurozone GDP miss, strong German inflation
Despite cash infusion, Windtree still faces money running out within a year
Pain medicine biotech Latigo taps CRO founder for CMO role
Johnson & Johnson to buy heart failure implant company V-Wave for up to $1.7B
Talus Bio tacks on $11M to target hard-to-reach transcription factors
Pathalys raises $105M series B to prepare Japan-approved kidney disease drug for FDA
Denmark’s Adcendo signs $1B biobuck deal for Multitude’s anti-TF ADC
Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues
Avantor sells clinical services unit to private equity firm for $650M
‘We’re pretty prolific’: Lilly Catalyze360 looks to connect with emerging biotechs across ‘all areas’
FDA clears its first at-home blood test for syphilis